
Overview
Ronald L. Hrebinko, MD, is a professor of urology at the University of Pittsburgh School of Medicine. He specializes in all genitourinary cancers with special expertise in continent urinary diversion, nephron-sparing surgery for renal cancer, laparoscopic kidney surgery, nerve-sparing surgery for the prostate, and testis cancer.Dr. Hrebinko is board-certified in urology. He received an undergraduate degree with honors from Dartmouth College in N.H., and a medical degree at the University of Pittsburgh School of Medicine. Dr. Hrebinko completed a residency at UPMC in the Department of Surgery, and a fellowship at Roswell Park Cancer Institute, in Buffalo, N.Y.Dr. Hrebinko is a member of professional organizations, such as the American Urologic Association, Society of Urologic Oncology, and the American Society of Clinical Oncology.Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule.
Dr. Hrebinko is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Wilms Tumor, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.
Dr. Hrebinko is board certified in American Board Of Urology. He is actively involved in clinical research, co-authoring 14 peer reviewed articles and participating in 2 clinical trials. Dr. Hrebinko is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5200 Centre Avenue, Suite 209, Pittsburgh, PA 15232
1300 Oxford Drive, Suite 1200, Bethel Park, PA 15102
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Office
Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.
UPMC Presbyterian
Jason Luke is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Luke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
Frequently Asked Questions about Dr. Ronald L. Hrebinko
How do I make an appointment with Dr. Ronald L. Hrebinko?
You can book an appointment with Dr. Ronald L. Hrebinko by calling their office at 412-605-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ronald L. Hrebinko a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ronald L. Hrebinko is classified as an Distinguished expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ronald L. Hrebinko specialize in?
While Dr. Ronald L. Hrebinko is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), Wilms Tumor, and WT1-Related Wilms Tumor Syndromes. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Ronald L. Hrebinko participate in research or clinical trials?
Yes. Dr. Ronald L. Hrebinko has published 14 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Ronald L. Hrebinko's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ronald L. Hrebinko accept my insurance?
Dr. Ronald L. Hrebinko accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-605-3000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Renal Cell Carcinoma (RCC)Dr. Hrebinko isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Adult Soft Tissue SarcomaDr. Hrebinko isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Hrebinko isAdvanced. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Hrebinko isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Hrebinko isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Hrebinko isAdvanced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Hrebinko isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- NephrectomyDr. Hrebinko isAdvanced. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder CancerDr. Hrebinko isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Reconstructive Urology SurgeryDr. Hrebinko isAdvanced. Learn about Reconstructive Urology Surgery.
- Upper Tract Urothelial Carcinoma (UTUC)
- Urothelial CancerDr. Hrebinko isAdvanced. Learn about Urothelial Cancer.
- Wilms TumorDr. Hrebinko isAdvanced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Hrebinko isAdvanced. Learn about WT1-Related Wilms Tumor Syndromes.
- Experienced
- Bladder ReconstructionDr. Hrebinko isExperienced. Learn about Bladder Reconstruction.
- BoilsDr. Hrebinko isExperienced. Learn about Boils.
- CarbuncleDr. Hrebinko isExperienced. Learn about Carbuncle.
- Familial Prostate CancerDr. Hrebinko isExperienced. Learn about Familial Prostate Cancer.
- FolliculitisDr. Hrebinko isExperienced. Learn about Folliculitis.
- LiposarcomaDr. Hrebinko isExperienced. Learn about Liposarcoma.
- Prostate CancerDr. Hrebinko isExperienced. Learn about Prostate Cancer.
- ProstatectomyDr. Hrebinko isExperienced. Learn about Prostatectomy.
- Renal OncocytomaDr. Hrebinko isExperienced. Learn about Renal Oncocytoma.
- UreteroscopyDr. Hrebinko isExperienced. Learn about Ureteroscopy.
